212 related articles for article (PubMed ID: 28579181)
1. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.
Hassan MM; Botrus G; Abdel-Wahab R; Wolff RA; Li D; Tweardy D; Phan AT; Hawk E; Javle M; Lee JS; Torres HA; Rashid A; Lenzi R; Hassabo HM; Abaza Y; Shalaby AS; Lacin S; Morris J; Patt YZ; Amos CI; Khaderi SA; Goss JA; Jalal PK; Kaseb AO
Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1791-1799. PubMed ID: 28579181
[TBL] [Abstract][Full Text] [Related]
2. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
[TBL] [Abstract][Full Text] [Related]
3. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
[TBL] [Abstract][Full Text] [Related]
5. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
6. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.
Hassan MM; Abdel-Wahab R; Kaseb A; Shalaby A; Phan AT; El-Serag HB; Hawk E; Morris J; Singh Raghav KP; Lee JS; Vauthey JN; Bortus G; Torres HA; Amos CI; Wolff RA; Li D
Gastroenterology; 2015 Jul; 149(1):119-29. PubMed ID: 25836985
[TBL] [Abstract][Full Text] [Related]
7. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma.
Chen VL; Le AK; Kim NG; Kim LH; Nguyen NH; Nguyen PP; Zhao C; Nguyen MH
Clin Gastroenterol Hepatol; 2016 Jun; 14(6):887-895.e1. PubMed ID: 26820401
[TBL] [Abstract][Full Text] [Related]
8. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
9. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk.
Yu MW; Chang HC; Chang SC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
Hepatology; 2003 Dec; 38(6):1393-400. PubMed ID: 14647050
[TBL] [Abstract][Full Text] [Related]
10. Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China.
Li X; Xu H; Ding Z; Jin Q; Gao P
Medicine (Baltimore); 2016 Dec; 95(49):e5587. PubMed ID: 27930575
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.
Dehara M; Kullberg S; Bixo M; Sachs MC; Grunewald J; Arkema EV
Eur J Epidemiol; 2024 Mar; 39(3):313-322. PubMed ID: 38212490
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
13. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.
Hassan MM; Spitz MR; Thomas MB; El-Deeb AS; Glover KY; Nguyen NT; Chan W; Kaseb A; Curley SA; Vauthey JN; Ellis LM; Abdalla E; Lozano RD; Patt YZ; Brown TD; Abbruzzese JL; Li D
Int J Cancer; 2008 Oct; 123(8):1883-91. PubMed ID: 18688864
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.
Hosokawa T; Kurosaki M; Tsuchiya K; Matsuda S; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Nakata T; Nishimura T; Suzuki S; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Izumi N
World J Gastroenterol; 2013 Jan; 19(2):249-57. PubMed ID: 23345948
[TBL] [Abstract][Full Text] [Related]
15. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
16. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
[TBL] [Abstract][Full Text] [Related]
17. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
18. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink.
McGlynn KA; Hagberg K; Chen J; Braunlin M; Graubard BI; Suneja N; Jick S; Sahasrabuddhe VV
Int J Cancer; 2016 May; 138(9):2146-53. PubMed ID: 26662112
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
